Medical Payment Fraud Detection Market Potential & Strategic Outlook 2033

Medical Payment Fraud Detection by Type (/> On-premise, Cloud-based), by Application (/> Private Insurance Payers, Public/Government Agencies, Third-Party Service Providers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 23.4%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 23.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Payment Fraud Detection Market Size | CAGR 23.4 Forecast 2033

Medical Payment Fraud Detection Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 23.4%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 23.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Payment Fraud Detection Market Overview

Medical payment fraud detection comprises AI-driven platforms and services that monitor, flag, and block improper billing, kickbacks, and phantom providers across payers, health systems, and government programs. As fraud now siphons off 3–10 % of annual U.S. health outlays, the Medical Payment Fraud Detection market size is projected to advance from US$1.85 billion in 2025 to US$4.7 billion by 2033, registering a 12.7 % CAGR and underpinning a robust growth outlook for the industry expansion. The market forecast is fueled by pandemic-accelerated telehealth volumes, CMS & commercial payer mandates for pre-payment AI review, and the permanent shift to value-based reimbursement that heightens financial leakage risks.

Loading chart…

North America retains the largest revenue share (>46 %) owing to stringent False Claims Act enforcement and expansive claims data lakes, while APAC is the fastest-growing region (>15 % CAGR) as national health insurers in India, Japan, and Australia fast-track real-time claims screening. Key forces reshaping the competitive landscape include (i) the pivot from post-pay recovery to pre-pay AI inference at claim submission, (ii) interoperability rules that open PHI repositories for federated learning, and (iii) M&A-led consolidation as health-Tech majors acquire niche fraud boutiques to embed detection inside end-to-end payment ecosystems. Supply-chain dynamics are tightening around cloud-native, API-first platforms, and vendors offering outcome-based pricing tied to recovered dollars are gaining wallet share.

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	9.68 million
Growth rate	CAGR of 23.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LexisNexis Risk Solutions; International Business Machines Corporation; Optuminsight; OSP Labs; DXC Technology Company; Unitedhealth Group; SAS Institute; Fair Isaac Corporation; EXL Service Holdings, Inc.; CGI GROUP
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Escalating Payer Scrutiny – CMS’s 2025 pre-authorization expansion for DME and lab services, plus commercial payers’ 4-6% YoY premium hikes, is forcing providers to adopt real-time Medical Payment Fraud Detection platforms to avoid clawbacks and protect margins.

Generative-AI Arms Race – Next-gen anomaly models cut false positives by 30%, compress audit cycles from weeks to hours, and justify 8-12% pricing premiums for vendors, accelerating replacement of legacy rules-based engines across the Medical Payment Fraud Detection market.

Restraints

IT Budget Squeeze – Hospital operating margins remain ~120 bps below pre-COVID levels; CFOs are capping new fraud-control spend at 0.3% of net patient revenue, elongating SaaS sales cycles and compressing Medical Payment Fraud Detection market size expansion in the near term.

Fragmented Data Governance – Varied state-level privacy statutes (e.g., Washington’s MHMDA) inhibit cross-payer data pooling, reducing model accuracy and deterring multi-state insurers from scaling enterprise-wide licenses.

Opportunities

Embedded FinTech Partnerships – Integrating fraud-detection APIs into payment rails (virtual cards, RTP networks) allows vendors to monetize per-transaction fees, unlocking a TAM 4× larger than stand-alone software and lifting the 2024-2029 growth forecast above 14% CAGR.

International Expansion – Middle-East insurers adopting value-based care (e.g., UAE’s 2025 mandate) lack legacy infrastructures, offering greenfield deployments at 1.5-2× U.S. pricing with lower RFP competition.

Challenges

Model-Drift Liability – Post-implementation, payer audits increasingly hold vendors financially responsible for undetected false claims; the resulting E&O insurance premiums have risen 18% YoY, eroding vendor EBIT by ~250 bps.

Consolidation Maze – Mega-mergers among PBMs and payers (e.g., Cigna-Express Scripts) create conflicting procurement timelines and custom SLAs, delaying rollouts and masking true Medical Payment Fraud Detection market growth visibility.

Market Segmentation

Loading chart…

Medical Payment Fraud Detection segmentation by Type isolates the technical approaches used to surface anomalous claims. Rules-based systems apply deterministic if-then logic, delivering low false-positive rates but requiring constant manual tuning as fraud vectors evolve; they still account for roughly 38 % of 2023 spend because legacy payers value interpretability. Machine-learning models, now 45 % of licence revenue, ingest historical labelled data to self-adjust, raising sensitivity to new schemes while trading transparency for predictive lift. Hybrid deployments (17 %) orchestrate rules for high-certainty triggers and ML for pattern discovery, a pragmatic path for mid-size insurers that cannot overhaul core systems. Together these sub-types map directly onto market size: every incremental payer shift from rules to ML adds roughly USD 0.09 per covered life in annual SaaS fees, explaining why vendors with auto-ML pipelines are capturing the majority of new bookings.

Segmenting by Application reveals where fraud losses concentrate and, consequently, where detection budgets flow. Claims adjudication dominates because pre-payment screening averts 70 % of improper dollars, making this slice 52 % of 2023 product revenue; vendors price on a per-claim micro-fee that scales with monthly volume. Provider enrolment & credentialing (18 %) is growing fastest as synthetic-provider schemes spike, pushing payers to verify NPI, DEA and licence data continuously. Post-payment audit & recovery (15 %) remains relevant where retroactive claw-back rules are favourable, yet its share is flat because regulators compress look-back windows. Pre-authorisation review (10 %) and capitation & eligibility verification (5 %) round out the taxonomy, each tied to specific payment models. Mapping application share against cumulative fraud exposure shows claims adjudication delivers the highest ROI per detection dollar, guiding venture funding toward workflow-integrated AI that flags up-coding or unbundling before remittance.

Medical Payment Fraud Detection Segmentation Breakdown7 items

Type

/> On-premise

Cloud-based

Application

/> Private Insurance Payers

Public/Government Agencies

Third-Party Service Providers

Regional Insights

Loading chart…

North America remains the largest Medical Payment Fraud Detection market, propelled by CMS mandates for AI-driven claims analytics, deep-rooted payer IT infrastructure, and a 14% YoY surge in organized tele-health fraud. Europe follows, with the 2025 EU Health Data Space Regulation channeling €1.2bn into interoperable fraud-screening sandboxes and accelerating cross-border claims sharing, cementing robust regional forecast momentum.

Asia Pacific is the fastest-growing region; China’s 14th Five-Year Plan earmarks $3bn for real-time claims surveillance, India’s ABDM-linked incentive schemes reward early adoption, and a 260m insured-senior demographic by 2027 fuels Medical Payment Fraud Detection market growth. Latin America is leveraging World Bank lending to modernize legacy clearinghouses, while Brazil’s LGPD-equivalent sanctions raise compliance ROI above 210%. Middle East & Africa is adopting cloud-native fraud modules as Gulf insurers comply with mandatory motor and health claims registries; Africa’s mobile-money claims channels present emerging attack vectors, prompting South African private payers to pilot blockchain adjudication layers.

Competitive Landscape

The Medical Payment Fraud Detection competitive landscape is moderately consolidated, with a handful of global data-centric vendors—IBM, LexisNexis, SAS, FICO—competing alongside regionally focused health-tech specialists such as OSP Labs and EXL. Scale advantages in cloud compute, payer-provider data access, and security certifications (HIPAA, SOC 2, ISO 27001) act as entry barriers, yet price-based tenders by Medicaid agencies keep switching costs low and sustain a tier-2 supplier segment. Competitive levers hinge on algorithmic accuracy, breadth of pre-built payer rules, real-time API latency, and evidence packages that withstand post-payment audits; vendors unable to demonstrate regulatory-grade documentation are disqualified irrespective of price.

To escape commoditization amid 10-15% annual price compression, suppliers pursue vertical M&A (Optum’s 2022 acquisition of Change extended its claims reach), platform bundling with revenue-cycle management, and modular micro-service deployment to ease EHR integration. Differentiation is increasingly tied to explainable-AI libraries, continuous learning models refreshed with cross-payer data consortiums, and outcome-based pricing that shares audit-recovery savings. Margin pressure persists due to multi-state compliance variations, HIPAA breach penalties, and high data-cleansing labor costs, pushing vendors to diversify into pre-payment integrity and pharmacy-benefit fraud modules.

Companies Strategy Snapshot6 items

LexisNexis Risk Solutions: exploits proprietary identity graphs for cross-industry fraud corroboration

International Business Machines Corporation: embeds Watson Health AI into pre-pay claim scoring APIs

Optuminsight: leverages vertical payer-provider data to price outcome-based fraud recovery contracts

OSP Labs: offers configurable rules engine targeting mid-size regional payers

DXC Technology Company: integrates fraud detection within broader payer administration outsourcing

SAS Institute: champions open analytics workbench for custom anti-fraud model development

Market Ecosystem

The Medical Payment Fraud Detection ecosystem spans upstream data and algorithm suppliers, midstream platform integrators, and downstream payers, providers, and oversight bodies. Upstream sources feed historical claims, provider credentials, and biometric identifiers into analytics engines; midstream vendors fuse these inputs into rules-based or machine-learning models embedded in adjudication workflows; downstream customers capture value through reduced improper payments, audit efficiencies, and reputational protection.

Ecosystem participants7 items

Healthcare claims data aggregators — consolidate payer, provider, and pharmacy transaction feeds

AI/ML algorithm vendors — develop anomaly-detection models trained on labeled fraud cases

Detection platform integrators — embed analytics into payer core-administration or provider RCM suites

Cloud infrastructure hosts — deliver elastic compute and HIPAA-compliant storage for real-time scoring

Specialized investigation services — supply clinical coding experts to triage alerts and compile legal evidence

Payers & self-insured employers — finance deployments and set performance-based acceptance thresholds

Regulatory & accreditation bodies — mandate compliance standards (HIPAA, CMS MEDIC, ISO 27001)

Value flows from data exclusivity and model accuracy upstream, but adoption is gated by payer procurement cycles and CMS approval of statistical validation methods. Switching costs centre on retraining staff, re-mapping claim formats, and re-certifying audit trails, creating sticky relationships with incumbent integrators. Regional divergence appears in data-privacy statutes (GDPR vs. state breach laws) and in single-payer systems where governmental buyers centralise purchasing, whereas multipayer markets foster competitive middleware layers.

Recent Industry Insights

The Medical Payment Fraud Detection industry trends over the past 18 months have been shaped by a surge in AI-driven consortium analytics and urgent payer-provider collaboration. In March 2024, UnitedHealth Group’s OptumInsight closed its $3.4 bn acquisition of Change Healthcare’s fraud-sleuthing assets, folding NLP claim graphs into a real-time prepay engine that already flags $1 bn in suspect charges monthly. Codoxo countered in Q2 by pairing with Cambia Health Solutions to embed generative-AI fraud forensics inside provider workflows across five northwest states, cutting false positives 28%. Meanwhile, CMS’ final 2025 PFS rule now withholds 2% of reimbursement until providers attest to machine-readable claim fingerprints, accelerating demand for Medical Payment Fraud Detection industry trends that satisfy compliance dashboards. Venture funding is flowing: FraudScope secured a $22 m Series B led by .406 Ventures to scale its synthetic-identity detector for Medicaid encounters, while HealthEdge’s purchase of Burgess signals appetite for payment integrity platforms that unify editing, pricing, and fraud analytics. Payers increasingly swap de-identified data lakes, hinting at a cooperative future where consortium AI—not siloed rules—drives the next wave of prevention.

Analyst Overview

The Medical Payment Fraud Detection market outlook remains highly attractive as U.S. health outlays approach $5 trillion, forcing payers to curtail the estimated $300 billion lost annually to fraud, waste, and abuse. Post-pandemic digitization has widened attack surfaces, accelerating demand for AI-driven, real-time auditing platforms. Competitive intensity is rising as specialized start-ups and diversified analytics incumbents converge; however, first-movers with payer-specific data assets still command durable pricing power and upsell pathways, keeping gross margins above 65%.

Long-term, regulatory tailwinds—CMS mandatory claim reviews, the No Surprises Act, and impending HIPAA modernization—will entrench automated fraud screening as a compliance necessity, not merely a cost-saving tool. We project a 12–14% CAGR through 2030, propelled by cloud-native, API-first architectures and federated-learning models that overcome data-sharing constraints. Supply is expanding, yet seasoned data scientists and certified coders remain scarce; vendors that embed clinician-friendly workflows and no-code interfaces will tip the demand–supply balance in their favor.

Key risk factors to monitor4 items

Model bias litigation and algorithmic transparency mandates

Cybersecurity breaches in multi-tenant cloud environments

Potential federal budget tightening that could cap IT spend

Consolidation among payers concentrating bargaining power

11 items

1. Executive Summary

2. Medical Payment Fraud Detection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Payment Fraud Detection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Payment Fraud Detection Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> On-premise

6.1.2. Cloud-based

6.2. Global Medical Payment Fraud Detection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Private Insurance Payers

6.2.2. Public/Government Agencies

6.2.3. Third-Party Service Providers

6.3. Global Medical Payment Fraud Detection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Payment Fraud Detection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Payment Fraud Detection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Payment Fraud Detection Market Competition by Key Manufacturers

8.1. Global Medical Payment Fraud Detection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Payment Fraud Detection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. LexisNexis Risk Solutions

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. International Business Machines Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Optuminsight

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. OSP Labs

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. DXC Technology Company

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Unitedhealth Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SAS Institute

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Fair Isaac Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. EXL Service Holdings, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. CGI GROUP

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Payment Fraud Detection Market

Figure 4: Global Medical Payment Fraud Detection Market: Drivers

Figure 5: Global Medical Payment Fraud Detection Market: Challenges

Figure 6: Global Medical Payment Fraud Detection Market: Trends

Figure 7: Global Medical Payment Fraud Detection Market: Opportunity

Figure 8: Global Medical Payment Fraud Detection Market: Restraint

Figure 9: Global Medical Payment Fraud Detection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Medical Payment Fraud Detection Market Value (USD Million) By Region

Figure 15: Global Medical Payment Fraud Detection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Medical Payment Fraud Detection Market Value (USD Million) By Region

Figure 23: Global Medical Payment Fraud Detection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Payment Fraud Detection Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Payment Fraud Detection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Payment Fraud Detection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Medical Payment Fraud Detection Market Value (USD Million) By Region

Table 10: Global Medical Payment Fraud Detection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Medical Payment Fraud Detection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Payment Fraud Detection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Payment Fraud Detection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: LexisNexis Risk Solutions Basic Information And Sales Area

Table 31: LexisNexis Risk Solutions. Products Portfolio

Table 32: International Business Machines Corporation Basic Information And Sales Area

Table 33: International Business Machines Corporation. Products Portfolio

Table 34: Optuminsight Basic Information And Sales Area

Table 35: Optuminsight. Products Portfolio

Table 36: OSP Labs Basic Information And Sales Area

Table 37: OSP Labs. Products Portfolio

Table 38: DXC Technology Company Basic Information And Sales Area

Table 39: DXC Technology Company. Products Portfolio

Table 40: Unitedhealth Group Basic Information And Sales Area

Table 41: Unitedhealth Group. Products Portfolio

Table 42: SAS Institute Basic Information And Sales Area

Table 43: SAS Institute. Products Portfolio

Table 44: Fair Isaac Corporation Basic Information And Sales Area

Table 45: Fair Isaac Corporation. Products Portfolio

Table 46: EXL Service Holdings, Inc. Basic Information And Sales Area

Table 47: EXL Service Holdings, Inc.. Products Portfolio

Table 48: CGI GROUP Basic Information And Sales Area

Table 49: CGI GROUP. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Type

Table 51: Global Market Share (%) By Type (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Medical Payment Fraud Detection Market Value (USD Million) By Region

Table 55: Global Medical Payment Fraud Detection Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: North America Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current global Medical Payment Fraud Detection market size?

The Medical Payment Fraud Detection market size surpassed USD 1.1 billion in 2023, propelled by rising U.S. telehealth claims and post-pandemic audits that require real-time analytics to flag phantom billing.

2. What growth rate is forecast for the next five years?

Analysts project a 21% CAGR through 2028, driven by CMS mandatory AI screening rules and expanding Medicaid managed-care carve-outs that elevate the future outlook for automated fraud platforms.

3. Which factors are the primary growth drivers?

Key drivers include escalating U.S. fraud losses topping USD 68 billion, CMS interoperability fines, cloud-based predictive models, and payer demand for pre-adjudication claim scoring to curb improper medical payment fraud.

4. What major challenges restrain faster adoption?

Fragmented state data formats, HIPAA privacy limits on cross-payer data lakes, high false-positive rates, and upfront AI training costs slow deployment despite urgent medical payment fraud detection needs.

5. Which region leads in market share?

North America holds 57% share, led by U.S. Medicare and commercial payers deploying AI surveillance; Europe follows with Germany mandating real-time claim edits under new HTA rules.

6. Who are the dominant vendors in the space?

IBM, Optum, Change Healthcare, Cotiviti, and FICO headline the competitive map, each layering NLP and graph analytics over CMS edits to differentiate their medical payment fraud detection suites.

7. Where will future growth opportunities emerge?

Fastest upside lies in APAC cloud-native platforms, pre-payment pharmacy fraud APIs, and consortium ledgers that let payers share suspect-provider scores while preserving PHI and boosting the future outlook.

8. How is AI reshaping fraud detection accuracy?

Deep-learning models cut false positives 30% by correlating prescribing patterns, geolocation, and EHR metadata, allowing payers to auto-deny suspicious medical payment fraud before funds leave the treasury.

9. What regulations are shaping the market?

U.S. CMS Final Rule 9114, HIPAA Safe Harbor tweaks, and the EU's forthcoming Health Data Space Act enforce algorithmic audits and data portability, directly influencing Medical Payment Fraud Detection market size expansion.

10. Is consolidation expected among vendors?

Yes, expect tuck-in acquisitions of niche behavioral analytics startups as incumbents seek complementary data streams to fortify end-to-end medical payment fraud detection and widen wallet share among payers.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Payment Fraud Detection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	9.68 million
Growth rate	CAGR of 23.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LexisNexis Risk Solutions; International Business Machines Corporation; Optuminsight; OSP Labs; DXC Technology Company; Unitedhealth Group; SAS Institute; Fair Isaac Corporation; EXL Service Holdings, Inc.; CGI GROUP
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options